Adaptimmune Announces Appointment of Cintia Piccina as

PHILADELPHIA and OXFORDSHIRE, United Kingdom, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to...

Related Keywords

Sao Paulo ,Sãpaulo ,Brazil ,Oxfordshire ,United Kingdom ,United States ,Philadelphia ,Pennsylvania ,Adrian Rawcliffe ,Julip Miller ,Exchange Commission ,Gene Strategy Program Management Office ,Nasdaq ,University Of Sao Paulo ,Novartis ,Corporate Affairs ,Cintia Piccina ,Chief Commercial Officer ,Chief Executive ,Global Oncology Cell ,Gene Strategy ,Program Management Office ,Escola Superior De Propaganda ,Specific Peptide Enhanced Affinity Receptor ,Private Securities Litigation Reform Act ,Quarterly Report ,Investor Relations ,Nasdaq Adap ,Adaptimmune Therapeutics Plc ,Dap ,Adaptimmune ,